Editor’s note: Scores of family and friends gathered on March 9, 2020, to honor the life of Cyndi Rose McHolland Boome following a years-long battle against cancer. But Cyndi’s battle against disease actually began 50 years earlier when a tumor was found in her right shoulder. Cyndi was the...
Read More
A new predictive model could reduce overtreatment of women with breast pre-cancers called ductal carcinoma in situ, researchers including one from Duke University say.
Read More
About one in seven breast cancers detected by mammography screening are over-diagnosed, according to a Duke Cancer Institute study designed to clarify the risk of breast cancer over-diagnosis using contemporary screening technology in the U.S.
Read More
BioAesthetics, which provides a nipple-areolar complex graft for patients undergoing breast reconstruction, is stepping up plans to commercialize its lead product after having closed on $5 million in financing.
Read More
EQRx, based in Cambridge, Mass., will gain exclusive rights to G1’s lerociclib in the United States, Europe, Japan and all other global markets, excluding the Asia-Pacific region (except Japan).
Read More
The FDA has OK’d the use of the drug tucatinib, or Tukysa, in combination with chemotherapy, for the treatment of adults with advanced forms of HER2-positive breast cancer that either cannot be removed with surgery, or has spread to other parts of the body.
Read More
Two new drugs for advanced HER2-positive breast cancer were tested in separate studies, and scientists say they’ve made progress in the development of new treatment options.
Read More
